Targeted Drug Delivery With Liposome Technology Reduces IOP, Maintains Results

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Wednesday, July 31, 2013

Ocular Surgery News

Subconjunctival injection of a liposome-latanoprost agent using nanotechnology reduced IOP in patients with glaucoma, and results were sustained through 3 months, a speaker said here.

Full Story

The steroid that is least likely to cause a posterior subcapsular cataract is:
1. dexamethsone
2. prednisolone
3. loteprednol
4. triamcinolone
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Targeted Drug Delivery With Liposome Technology Reduces IOP, Maintains Results

Comments

Quick Quiz

The steroid that is least likely to cause a posterior subcapsular cataract is:

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

VISUPLAN 500 Non-Contact Tonometer

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2